chr9-14722576-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005454.3(CER1):c.97G>A(p.Val33Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005454.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CER1 | NM_005454.3 | c.97G>A | p.Val33Ile | missense_variant | 1/2 | ENST00000380911.4 | NP_005445.1 | |
CER1 | XR_001746419.2 | n.158G>A | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CER1 | ENST00000380911.4 | c.97G>A | p.Val33Ile | missense_variant | 1/2 | 1 | NM_005454.3 | ENSP00000370297 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250878Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135646
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461278Hom.: 0 Cov.: 33 AF XY: 0.0000399 AC XY: 29AN XY: 726976
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.97G>A (p.V33I) alteration is located in exon 1 (coding exon 1) of the CER1 gene. This alteration results from a G to A substitution at nucleotide position 97, causing the valine (V) at amino acid position 33 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at